Physician

Shilpa Gulati, M.D.

According to 2025 Medicare claims, Shilpa Gulati, M.D. (NPI: 1417375577) practices ophthalmology in the Springfield, MA market, with the plurality of this provider's patient population coming from Hampden, MA. This provider's primary affiliated billing organization is NEW ENGLAND RETINA CONSULTANTS, PC (NPI: 1871659540; TIN: 20-2549471) and primary practice location at 01107-1139.

Gulati's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 772 traditional Medicare patients, billed 33,808 HCPCS/CPT codes, and received $2,324,581 in Medicare payments. The top billing code was J0178 (Injection, aflibercept, 1 mg). Part D data shows 315 prescription claims across 110 beneficiaries totaling $10,294 in drug costs, led by Prednisolone Acetate (Prednisolone Acetate). Open Payments data shows 19 records totaling $134,162. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved sharply higher in recent years, from $7,022 to $2,324,581. Concurrently, Part D prescription costs have moved up and down with repeated peaks and valleys, starting at $18,011 and ending at $10,294. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$1.3M$2.5M2018 Medicare payment: $7,022 (USD; Tot_Mdcr_Pymt_Amt)2019 Medicare payment: $21,722 (USD; Tot_Mdcr_Pymt_Amt)2020 Medicare payment: $215,018 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $882,926 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $1,750,653 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $2,504,742 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $2,324,581 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
2015N/RN/RN/R
2016N/RN/RN/R
2017N/RN/RN/R
20184981$7,022
2019111145$21,722
20202851,217$215,018
20216005,100$882,926
20228249,761$1,750,653
202396326,114$2,504,742
202477233,808$2,324,581

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$24K$47K2015 Drug cost: $18,011 (USD; Tot_Drug_Cst)2016 Drug cost: $14,600 (USD; Tot_Drug_Cst)2017 Drug cost: $47,395 (USD; Tot_Drug_Cst)2018 Drug cost: $31,810 (USD; Tot_Drug_Cst)2019 Drug cost: $29,731 (USD; Tot_Drug_Cst)2020 Drug cost: $24,675 (USD; Tot_Drug_Cst)2021 Drug cost: $35,775 (USD; Tot_Drug_Cst)2022 Drug cost: $24,008 (USD; Tot_Drug_Cst)2023 Drug cost: $21,075 (USD; Tot_Drug_Cst)2024 Drug cost: $10,294 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
201557179$18,011
201663174$14,600
2017102326$47,395
2018100269$31,810
201986213$29,731
202091231$24,675
2021120492$35,775
2022157510$24,008
2023122412$21,075
2024110315$10,294

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
J0178Injection, aflibercept, 1 mg1821,674$656
67028Injection of drug into eye3541,410$93
92014Established patient complete exam of visual system582744$89
99213Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more325414$68
92134Imaging of retina7271,948$30

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
Prednisolone AcetatePrednisolone Acetate1215,126$6,089
OfloxacinOfloxacin682,344$1,205
Ketorolac TromethamineKetorolac Tromethamine311,585$513
Dorzolamide-TimololDorzolamide Hcl/Timolol Maleat281,904$504
Brimonidine TartrateBrimonidine Tartrate261,931$212

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.17$9,928Regeneron Pharmaceuticals, Inc.
Research PaymentsReported research-related payment or transfer-of-value amount.2$124,234EyePoint Pharmaceuticals US, Inc.
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Shilpa Gulati, M.D.?

Tedicare shows public-source Medicare data for Shilpa Gulati, M.D. (NPI 1417375577), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Shilpa Gulati, M.D. have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Shilpa Gulati, M.D.?

Shilpa Gulati, M.D. is linked to NEW ENGLAND RETINA CONSULTANTS, PC (billing NPI 1871659540) in the available physician profile data.

Does Shilpa Gulati, M.D. have Open Payments data?

Shilpa Gulati, M.D. has 19 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.